114 related articles for article (PubMed ID: 33666541)
1. miR-557 suppressed the malignant behaviours of osteosarcoma cells by reducing HOXB9 and deactivating the EMT process.
Wang Y; Hao W; Wang H
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):230-239. PubMed ID: 33666541
[TBL] [Abstract][Full Text] [Related]
2. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
3. MiR-196a promoted cell migration, invasion and the epithelial-mesenchymal transition by targeting HOXA5 in osteosarcoma.
Wang X; Zhang L; Zhang X; Xing C; Liu R; Zhang F
Cancer Biomark; 2020; 29(2):291-298. PubMed ID: 32675397
[TBL] [Abstract][Full Text] [Related]
4. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.
Guo X; Zhang J; Pang J; He S; Li G; Chong Y; Li C; Jiao Z; Zhang S; Shao M
Tumour Biol; 2016 Jul; 37(7):9181-7. PubMed ID: 26768615
[TBL] [Abstract][Full Text] [Related]
6. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway.
Fu Y; Tang Y; Wang J; Guo Z
Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735
[TBL] [Abstract][Full Text] [Related]
8. miR-19 Promotes Cell Proliferation, Invasion, Migration, and EMT by Inhibiting SPRED2-mediated Autophagy in Osteosarcoma Cells.
Xie C; Liu S; Wu B; Zhao Y; Chen B; Guo J; Qiu S; Cao YM
Cell Transplant; 2020; 29():963689720962460. PubMed ID: 33023313
[TBL] [Abstract][Full Text] [Related]
9. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
10. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma.
Zhang Z; Zhang M; Chen Q; Zhang Q
Cancer Gene Ther; 2017 Feb; 24(2):83-88. PubMed ID: 28186090
[TBL] [Abstract][Full Text] [Related]
12. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1.
Liu Y; Zhang J; Xing C; Wei S; Guo N; Wang Y
Cancer Biomark; 2018; 23(2):269-277. PubMed ID: 30103304
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
15. miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1.
Cai Q; Zeng S; Dai X; Wu J; Ma W
Oncol Rep; 2017 Nov; 38(5):2993-3000. PubMed ID: 29048685
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
[TBL] [Abstract][Full Text] [Related]
17. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells.
Sha L; Dong L; Lv L; Bai L; Ji X
Clin Exp Med; 2015 Feb; 15(1):55-64. PubMed ID: 25081022
[TBL] [Abstract][Full Text] [Related]
18. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1.
Jiang R; Zhang C; Liu G; Gu R; Wu H
J Cell Biochem; 2017 Nov; 118(11):3765-3774. PubMed ID: 28379605
[TBL] [Abstract][Full Text] [Related]
20. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
